Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Oliveira de Almeida

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMB Reports|July 9, 2020
Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processesBruna Oliveira de Almeida, João Agostinho Machado-Neto
Gene|March 2, 2025
Exploring the dual role of SIVA1 in cancer biologyNatália Sudan Parducci, Anali Del Milagro Bernabe Garnique, Bruna Oliveira de Almeida, et al.
Translational Cancer Research|May 25, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategiesJuan Luiz Coelho-Silva, Natália Sudan Parducci, Maria Fernanda Lopes Carvalho, et al.
Investigational New Drugs|April 28, 2022
NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cellsJean Carlos Lipreri da Silva, Maria Fernanda Lopes Carvalho, Livia Bassani Lins de Miranda, et al.
ACS Omega|July 10, 2026
SIVA1 Knockdown Drives Aggressive Phenotypes in Triple-Negative Breast Cancer Cells while Enhancing Paclitaxel EfficacyNatália Sudan Parducci, Bruna Oliveira de Almeida, Anali Del Milagro Bernabe Garnique, et al.
Clinics (Sao Paulo, Brazil)|July 7, 2024
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cellsMaria Fernanda Lopes Carvalho, Carolina Santana Calicchio, Bruna Oliveira de Almeida, et al.
Hematology, Transfusion and Cell Therapy|February 7, 2024
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agentsMaria Fernanda Lopes Carvalho, Bruna Oliveira de Almeida, Maura Lima Pereira Bueno, et al.
Oncology Letters|June 30, 2021
Targeting glioma cells by antineoplastic activity of reversineCamila Hirakata, Keli Lima, Bruna Oliveira De Almeida, et al.
Pharmacological Reports : PR|March 8, 2025
Eribulin exerts multitarget antineoplastic activity in glioma cellsGuilherme Augusto Sousa Alcântara, Mariane Cristina do Nascimento, Livia Bassani Lins de Miranda, et al.
Cancers|August 12, 2023
The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer CellsKeli Lima, Lívia Bassani Lins de Miranda, Anali Del Milagro Bernabe Garnique, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMB Reports|July 9, 2020
Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processesBruna Oliveira de Almeida, João Agostinho Machado-Neto
Gene|March 2, 2025
Exploring the dual role of SIVA1 in cancer biologyNatália Sudan Parducci, Anali Del Milagro Bernabe Garnique, Bruna Oliveira de Almeida, et al.
Translational Cancer Research|May 25, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategiesJuan Luiz Coelho-Silva, Natália Sudan Parducci, Maria Fernanda Lopes Carvalho, et al.
Investigational New Drugs|April 28, 2022
NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cellsJean Carlos Lipreri da Silva, Maria Fernanda Lopes Carvalho, Livia Bassani Lins de Miranda, et al.
ACS Omega|July 10, 2026
SIVA1 Knockdown Drives Aggressive Phenotypes in Triple-Negative Breast Cancer Cells while Enhancing Paclitaxel EfficacyNatália Sudan Parducci, Bruna Oliveira de Almeida, Anali Del Milagro Bernabe Garnique, et al.
Clinics (Sao Paulo, Brazil)|July 7, 2024
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cellsMaria Fernanda Lopes Carvalho, Carolina Santana Calicchio, Bruna Oliveira de Almeida, et al.
Hematology, Transfusion and Cell Therapy|February 7, 2024
Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agentsMaria Fernanda Lopes Carvalho, Bruna Oliveira de Almeida, Maura Lima Pereira Bueno, et al.
Oncology Letters|June 30, 2021
Targeting glioma cells by antineoplastic activity of reversineCamila Hirakata, Keli Lima, Bruna Oliveira De Almeida, et al.
Pharmacological Reports : PR|March 8, 2025
Eribulin exerts multitarget antineoplastic activity in glioma cellsGuilherme Augusto Sousa Alcântara, Mariane Cristina do Nascimento, Livia Bassani Lins de Miranda, et al.
Cancers|August 12, 2023
The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer CellsKeli Lima, Lívia Bassani Lins de Miranda, Anali Del Milagro Bernabe Garnique, et al.
Pageof 2